137 related articles for article (PubMed ID: 37736005)
1. Reducing hypoglycemia from overtreatment of type 2 diabetes in older adults: The HypoPrevent study.
Koehn DA; Dungan KM; Wallia A; Lucas DO; Lash RW; Becker MN; Dardick LD; Boord JB
J Am Geriatr Soc; 2023 Dec; 71(12):3701-3710. PubMed ID: 37736005
[TBL] [Abstract][Full Text] [Related]
2. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
[TBL] [Abstract][Full Text] [Related]
3. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward.
Wojszel ZB; Kasiukiewicz A
BMC Geriatr; 2019 Sep; 19(1):242. PubMed ID: 31477024
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
[TBL] [Abstract][Full Text] [Related]
5. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
7. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
[TBL] [Abstract][Full Text] [Related]
8. Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE Hypoglycemia Study.
Kalra S; Deepak MC; Narang P; Singh V; Uvaraj MG; Agrawal N
Diabetes Technol Ther; 2013 Feb; 15(2):129-35. PubMed ID: 23289432
[TBL] [Abstract][Full Text] [Related]
9. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes.
Alexopoulos AS; Kahkoska AR; Pate V; Bradley MC; Niznik J; Thorpe C; Stürmer T; Buse J
JAMA Netw Open; 2021 Nov; 4(11):e2132215. PubMed ID: 34726745
[TBL] [Abstract][Full Text] [Related]
10. Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults With Incident Type 2 Diabetes.
Zhong VW; Juhaeri J; Cole SR; Shay CM; Gordon-Larsen P; Kontopantelis E; Mayer-Davis EJ
J Clin Endocrinol Metab; 2019 Jun; 104(6):1989-1998. PubMed ID: 30608562
[TBL] [Abstract][Full Text] [Related]
11. Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration.
Laires PA; Tang J; Fan CP; Li Z; Qiu Y; Iglay K
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):213-220. PubMed ID: 27345181
[TBL] [Abstract][Full Text] [Related]
12. Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross-sectional study.
Matsuoka A; Hirota Y; Takeda A; Kishi M; Hashimoto N; Ohara T; Higo S; Yamada H; Nakamura T; Hamaguchi T; Takeuchi T; Nakagawa Y; Okada Y; Sakaguchi K; Ogawa W
J Diabetes Investig; 2020 Mar; 11(2):417-425. PubMed ID: 31461223
[TBL] [Abstract][Full Text] [Related]
13. Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
Le P; Ayers G; Misra-Hebert AD; Herzig SJ; Herman WH; Shaker VA; Rothberg MB
Diabetes Care; 2022 May; 45(5):1107-1115. PubMed ID: 35076695
[TBL] [Abstract][Full Text] [Related]
14. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
15. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
[TBL] [Abstract][Full Text] [Related]
16. Glucose Control, Sulfonylureas, and Insulin Treatment in Elderly People With Type 2 Diabetes and Risk of Severe Hypoglycemia and Death: An Observational Study.
Ling S; Zaccardi F; Lawson C; Seidu SI; Davies MJ; Khunti K
Diabetes Care; 2021 Apr; 44(4):915-924. PubMed ID: 33541857
[TBL] [Abstract][Full Text] [Related]
17. Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?
Schloot NC; Haupt A; Schütt M; Badenhoop K; Laimer M; Nicolay C; Reaney M; Fink K; Holl RW
Diabetes Metab Res Rev; 2016 Mar; 32(3):316-24. PubMed ID: 26409039
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
19. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
Lipska KJ; Ross JS; Miao Y; Shah ND; Lee SJ; Steinman MA
JAMA Intern Med; 2015 Mar; 175(3):356-62. PubMed ID: 25581565
[TBL] [Abstract][Full Text] [Related]
20. Predictors of nonsevere and severe hypoglycemia during glucose-lowering treatment with insulin glargine or standard drugs in the ORIGIN trial.
ORIGIN Trial Investigators
Diabetes Care; 2015 Jan; 38(1):22-8. PubMed ID: 25352653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
